Scientific exchange · Dr. Rosa Kimura

07 Aug 2026 · Phone · Dr. Rosa Kimura, Christie NHS Foundation Trust · MSL Mei Tanaka · Vantrexa

ReviewedVeeva CRMENG-0099—

Capture insight from this engagement

Location: Christie NHS Foundation Trust
Therapeutic area: Oncology
Country: United Kingdom
Stakeholder tier: Tier 2
Strategic objective: Not linked
Initiative: Not linked
MSL: MTMei TanakaMSL, Oncology (Japan)
Product: Vantrexa (vantrelimab)

Topics discussed

Comparator checkpoint monotherapy
Elderly / ECOG 2 patients
Duration of response

Scientific content used

VOYAGE-1 pivotal data summary

Questions raised

No questions recorded.

Notes

Scientific exchange with oncology pharmacist at Christie NHS Foundation Trust. Discussed comparator checkpoint monotherapy, elderly / ecog 2 patients, duration of response.

Insights captured (0)

Capture insight

No insights captured from this engagement.

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

No follow-ups recorded.

Quality ratings

1–5, rated at review

Scientific relevance: 3
Strategic relevance: 2
Depth of exchange: 5
Actionability: 3

Data lineage

Source system: Veeva CRM
Sync: Veeva CRM · synced 2026-09-15 08:00 UTC
System of record: Veeva CRM
Record id: ENG-0099

Audit history (0)

All create, update and approval events for this record

No audit events in sample data